UWIFIC, MCA to Establish Collaboration Framework
University of the West Indies’ Five Islands Campus and the Antigua and Barbuda Medicinal Cannabis Authority have formed a formal partnership to advance medicinal cannabis education and research within the developing industry. As reported by The Antigua and Barbuda ABC (Festival) Report, the Memorandum of Understanding, or MOU, was signed April 17, 2026 during the festival. Antigua Observer.
This is the first agreement of this kind that has been signed by the primary institution for higher education in the nation and its regulatory body responsible for medicinal cannabis. The agreement establishes the framework for collaborative research initiatives, academic programs, skills training and knowledge transfer within medicinal cannabis.
Partnership Strategic Objectives
MCA’s Chief Executive Officer Regis Burton said that this partnership aims to change the perception of the industry beyond the historical association it has had with recreational usage. Burton stressed the importance of evidence-based studies to demonstrate the effectiveness and value of medical products. Burton said, “If we want to make progress, and get away from the current situation, then we need to show that there are products with added value that exist in this space.”
Justin Robinson, UWIFIC principal professor, reaffirmed the commitment of the university to support the development and growth of Antiguans, Barbudans, and their health through this partnership. This MOU highlights several areas of key focus.
- Collaborative Research: The therapeutic potential of Cannabis.
- Develop Academic Programs: Create new educational offerings such as in cannabis extraction science, cannabis agronomy and quality assurance.
- Comment on Policy: Initiatives to influence national policy on medicinal cannabis.
- Support for Industry: The sector is promoting responsible growth.
Burton cited the College of Agriculture’s growing involvement in cannabis as another natural fit, furthering the integration of agricultural science and medicinal applications.
Legal character and future implementation
Jeniece Saint Romain, Crown Counsel at the Office of the attorney general who helped draft the MOU clarified the legal nature of the agreement. She said that it isn’t a legal contract. It is a statement by both parties of their intention to cooperate in an important area.
St Romain said that, as the relationship develops, details of specific projects, timelines and resources commitments would be detailed in subordinate agreements. It is common practice to use collaborative frameworks in this way, as both parties have signed the agreement with good faith. Now, the immediate goal is to move from the collaborative framework into actionable initiatives.
This strategic direction highlights the importance of new product development and responsible industry development. This strategic focus highlights the significance of the new Research on medicinal Cannabis Partnerships in education and training are essential to achieving the goals.
Disclaimer: The information contained in this article does not constitute medical advice. Hemp Gazette makes no medical diagnoses or recommendations. Before making decisions about your health, or any condition that may affect it, always consult with a medical professional. Therapeutic Goods Administration of Australia has not evaluated statements about the therapeutic benefits of cannabinoid products, hemp or cannabis. TGA regulates the access to medical cannabis in Australia.